Xiangtan Central Hospital

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Clinical Study of Active Intervention in High-risk HFpEF Patients

First Posted Date
2024-08-01
Last Posted Date
2024-08-01
Lead Sponsor
Xiangtan Central Hospital
Target Recruit Count
924
Registration Number
NCT06532019

Risk Factors In Heart Failure Patients With Preserved Ejection Fraction

First Posted Date
2024-07-05
Last Posted Date
2024-07-08
Lead Sponsor
Xiangtan Central Hospital
Target Recruit Count
9419
Registration Number
NCT06487468

Outcome of Discharged HFmrEF Patients

First Posted Date
2022-02-15
Last Posted Date
2022-02-15
Lead Sponsor
Xiangtan Central Hospital
Target Recruit Count
1693
Registration Number
NCT05240118

B-lines-guided Heart Failure Management in Heart Failure Patients

Active, not recruiting
Conditions
Lung Ultrasound
Heart Failure
Interventions
Diagnostic Test: Lung ultrasound
First Posted Date
2021-09-05
Last Posted Date
2024-06-28
Lead Sponsor
Xiangtan Central Hospital
Target Recruit Count
320
Registration Number
NCT05035459
Locations
🇨🇳

Xiangtan Central Hospital, Xiangtan, Hunan, China

Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS)

Phase 4
Recruiting
Conditions
Heart Failure
Anemia
Interventions
Drug: Dapagliflozin
Drug: Placebo
First Posted Date
2021-01-13
Last Posted Date
2024-07-01
Lead Sponsor
Xiangtan Central Hospital
Target Recruit Count
1990
Registration Number
NCT04707261
Locations
🇨🇳

Xiangtan Central Hospital, Xiangtan, Hunan, China

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy